Article
Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1
16 Dec 2020
Abstract excerpt
gene was amplified, and nuclear HSF1 abundance was markedly increased in prostate cancers and particularly in neuroendocrine prostate cancer (NEPC), for which there are no available treatment options. Despite genetic validation of HSF1 as a therapeutic target in a range of cancers, a direct and selective small-molecule HSF1 inhibitor has not been validated or developed for use in the clinic. We described the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
